Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02228889 · ClinicalTrials.gov registry record · NA
RCT of Two Noncrosslinked Porcine Acellular Dermal Matrices in Ab Wall Reconstruction
A NA study of Hernia, Ventral and Intestinal Fistula, sponsored by Jeffrey Janis.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
- 1
- Study location
NCT02228889 is a NA study of Hernia, Ventral and Intestinal Fistula that has completed, run by Jeffrey Janis. The registered enrollment target is 46 participants, below the 177-participant average among 7 other Hernia, Ventral trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02228889, a NA study of Hernia, Ventral and Intestinal Fistula, has completed, sponsored by Jeffrey Janis.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to compare the clinical outcomes of two commonly used, FDA-approved biologic meshes in hernia repair and abdominal wall reconstruction (Strattice and XenMatrix). The two meshes are derived from pig skin from which cells have been removed and which have been sterilized. The two meshes are made by two different companies using different processes.
Conditions Studied
Interventions
- PROCEDURE Abdominal wall reconstruction with Strattice
- OTHER Assess pain intensity at last office visit preoperatively
- OTHER Assess pain interference at last office visit preoperatively
- OTHER Assess physical functioning at last office visit preoperatively
- OTHER Assess patient quality of life at last office visit preoperatively
Study Locations (1)
Ohio
- The Ohio State University Wexner Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2015-01 |
| Est. Completion | 2025-03-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02228889
The ClinicalTrials.gov registry entry for NCT02228889 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 177-participant average among 7 other Hernia, Ventral trials with a reported enrollment target (74% lower). The listed sponsor is Jeffrey Janis, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Hernia, Ventral appearing as the primary indexed condition, and to 5 interventions - of which Abdominal wall reconstruction with Strattice is the first listed.
NCT02228889 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT02228889 about?
NCT02228889 is a clinical study titled "RCT of Two Noncrosslinked Porcine Acellular Dermal Matrices in Ab Wall Reconstruction". The purpose of the study is to compare the clinical outcomes of two commonly used, FDA-approved biologic meshes in hernia repair and abdominal wall reconstruction (Strattice and XenMatrix). The two meshes are derived from pig skin from which cells have been removed and which have been sterilized. Th...
What is the current status of trial NCT02228889?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2015-01. Estimated completion is 2025-03-27.
What conditions does trial NCT02228889 study?
This clinical trial studies the following conditions: Hernia, Ventral, Intestinal Fistula, Fibromatosis, Abdominal.
What interventions are being tested in trial NCT02228889?
The interventions under investigation include: Abdominal wall reconstruction with Strattice (PROCEDURE), Assess pain intensity at last office visit preoperatively (OTHER), Assess pain interference at last office visit preoperatively (OTHER), Assess physical functioning at last office visit preoperatively (OTHER), Assess patient quality of life at last office visit preoperatively (OTHER).
Who is sponsoring clinical trial NCT02228889?
This trial is sponsored by Jeffrey Janis, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02228889 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hernia, Ventral
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
GORE® ENFORM Biomaterial Product Study
RECRUITING · NA
-
Ventral or Inguinal Hernia, Robotically Repaired With OviTex Mesh
RECRUITING · NA
-
Transorb™ Self-Gripping Resorbable Mesh in High-risk Subjects Undergoing Open Repair of Ventral Hernia
ACTIVE NOT RECRUITING · NA
-
Laparoscopic Ventral Hernia Repair With Elastomeric Pain Pump
COMPLETED · NA
-
A Study to Understand the Utility of the Force Feedback Instruments in Robotic Procedures Using da Vinci 5 Robot
RECRUITING
-
Abdominal Wall Tension in Patients Undergoing Ventral Hernia Repair Without Component Separation
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.